Sahil Kirpekar
Förmögenhet: 523 831 $ per 2026-05-31
Förmögenhet: 523 831 $ per 2026-05-31
Sahil V.
Kirpekar is currently President, Chief Executive Officer & Director at Reunion Neuroscience, Inc. since 2026.
Formerly, served as Director at IntelGenx Technologies Corp.
from 2023 to 2024, Chief Business Officer at Atai Beckley NV from 2022 to 2025, and Head-Business Development at Otsuka Pharmaceutical Co., Ltd. Education includes graduate studies at the University of Cambridge.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
0,03 % | 2025-09-15 | 115 636 ( 0,03 % ) | 523 831 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Verkställande Direktör | 2026-06-15 |
| Företag | Position | Slut |
|---|---|---|
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Företagsledare/Principal | 2025-04-02 |
| INTELGENX TECHNOLOGIES CORP. | Direktör/Styrelseledamot | 2024-05-17 |
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and nutraceuticals | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and nutraceuticals | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IntelGenx Technologies Corp.
IntelGenx Technologies Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops and manufactures oral film therapeutics | Health Technology |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån